Covalent crosslinking of the heme prosthetic group to myoglobin by H2O2: Toxicological implications

Free Radical Biology and Medicine

Volumn 21, Issue 1, 1996, Pages 35-41

  Osawa, Yoichi ^a,b   Williams, Mark S ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Covalent alteration; Free radicals; H2O2; Heme; Ischemia reperfusion injury; Myoglobin; Oxidative modification; Toxicity

Indexed keywords

FREE RADICAL; HYDROGEN PEROXIDE; MYOGLOBIN;

ARTICLE; CELL DEATH; CELL VIABILITY; COVALENT BOND; CROSS LINKING; DNA ADDUCT; HEME SYNTHESIS; HUMAN; HUMAN CELL; ISCHEMIA; OXIDATIVE PHOSPHORYLATION; PINOCYTOSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN MODIFICATION; REPERFUSION INJURY;

EID: 0029957091     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/0891-5849(95)02215-5     Document Type: Article

References (63)

1. 1. Brodie, B. B.; Reid, W. D.; Cho, A. K.; Sipes, I. G.; Krishna, G.; Gillette, J. R. Possible mechanism of liver necrosis caused by aromatic organic compounds. Proc. Natl. Acad. Sci. USA 68:160-164; 1971.
2. 2. Correia, M. A.; Farrell, G. C.; Olson, S.; Wong, J. S.; Schmid, R.; Ortiz de Montellano, P. R.; Beilan, H. S.; Kunze, K. L.; Mico, B. A. Cytochrome P-450 heme moiety. The specific target in drug-induced heme alkylation. J. Biol. Chem. 256:5466-5470; 1981.
3. 3. Halpert, J. R.; Stevens, J. C. Cytochrome P-450 as a target of biological reactive intermediates. Adv. Exp. Med. Biol. 283:105-109; 1991.
4. 4. Ortiz de Montellano, P. R. Free radical modification of prosthetic heme groups. Pharmacol. Ther. 48:95-120; 1990.
5. 5. Osawa, Y. ; Coon, M. J. Selective mechanism-based inactivation of the major phenobarbital-inducible P-450 cytochrome from rabbit liver by phencyclidine and its oxidation product, the iminium compound. Drug. Metab. Dispos. 17:7-13; 1989.
6. 6. Osawa, Y.; Coon, M. J. Metabolism of phencylidine and its oxidation product, the iminium compound, leads to destruction of specific rabbit liver microsomal P-450 cytochromes. In: Domino, E. F.; Kamenka, J.-M., eds. Sigma and phencyclidine-like compounds as molecular probes in biology. Ann Arbor, MI: NPP Books; 1988:619-624.
7. 7. Osawa, Y.; Coon, M. J. Stereochemistry of functional group determines the mechanism of aromatase inhibition by 6-bromoandrostenedione. Endocrinology 121:1010-1016; 1987.
8. 8. Osawa, Y.; Yarborough, C; Osawa, Y. Norethisterone, a major ingredient of contraceptive pills, is a suicide inhibitor of estrogen biosynthesis. Science 215:1249-1251; 1982.
9. 9. Arnao, M. B.; Acosta, M.; del Rio, J. A.; Varon, R.; Garcia-Canovas, F. A kinetic study on the suicide inactivation of peroxidase by hydrogen peroxide. Biochem. Biophys. Acta 1041:43-47; 1990.
10. 10. Egan, R. W.; Paxton, J.; Kuehl, F. A. Mechanism for irreversible self-deactivation of prostaglandin synthetase. J. Biol. Chem. 251:7329-7335; 1976.
11. 11. Osawa, Y.; Korzekwa, K. Oxidative modification by low levels of HOOH can transform myoglobin into an oxidase. Proc. Natl. Acad. Sci. USA 88:7081-7085; 1991.
12. 3, in red cell lysates. J. Biol. Chem. 269:15481-15487; 1994.
13. 3 and molecular modeling of the oxidase form. J. Biol. Chem. 268:2953-2959; 1993.
14. 14. Osawa, Y.; Darbyshire, J. F.; Meyer, C. M.; Alayash, A. I. Differential susceptibilities of the prosthetic heme of hemoglobin-based red cell substitutes. Biochem. Pharmacol. 12:2299-2305; 1993.
15. 3: Covalent bonding of the proximal histidine to the ring I vinyl group. J. Biol. Chem. 266:3208-3214; 1991.
16. 3 myoglobin. J. Biol. Chem. 265:10340-10346; 1990.
17. 3. J. Am. Chem. Soc. 111:4462-4467; 1989.
18. 18. Farmer, P. B.; Neumann, H. G.; Henschler, D. Estimation of exposure of man to substances reacting covalently with macromolecules. Arch. Toxicol. 60:251-260; 1987.
19. 19. Haugen, D. A. Charge-shift strategy for isolation of hemoglobin-carcinogen adducts formed at the 93 cysteine sulfhydryl groups. Chem. Res. Toxicol. 2:379-385; 1989.
20. 3: Cross-linking of heme to cysteine residue 93. J. Biol. Chem. 267:8739-8743; 1992.
21. 21. Bryant, M. S.; Skipper, P. L.; Tannenbaum, S. R.; Maclure, M. Hemoglobin adducts of 4-aminobiphenyl in smokers and nonsmokers. Cancer Res. 47:602-608; 1987.
22. 22. Axworthy, D. B.; Hoffman, K.; Streeter, A. J.; Calleman, C. J.; Pascoe, G. A.; Baillie, T. A. Covalent binding of acetaminophen to mouse hemoglobin. Identification of major and minor adducts formed in vivo and implications for the nature of the arylating metabolites. Chem. Biol. Interact. 68:99-116; 1988.
23. 23. Gorelick, N. J.; Hutchins, D. A.; Tannenbaum, S. R.; Wogan, G. N. Formation of DNA and hemoglobin adducts of fluoranthene after single and multiple exposures. Carcinogenesis 10:1579-1587; 1989.
24. 24. Niketic, V.; Beslo, D.; Raicevic, S.; Sredic, S.; Stojkovic, M. Glutathione adduct of hemoglobin (Hb ASSG) in hemolysates of patients on long-term antiepileptic therapy. Int. J. Biochem. 24:503-507; 1992.
25. 25. Osawa, Y.; Pohl, L. R. Covalent bonding of the prosthetic heme to protein: A potential mechanism for the suicide inactivation or activation of hemoproteins. Chem. Res. Toxicol. 2:131-141; 1989.
26. 26. Halpert, J. Further studies of the suicide inactivation of purified rat liver cytochrome p-450 by chloramphenicol. Mol. Pharmacol. 21:166-172; 1982.
27. 27. Halpert, J.; Miller, N. E.; Gorsky, L. D. On the mechanism of the inactivation of the major phenobarbital-inducible isozyme of rat liver cytochrome P-450 by chloramphenicol. J. Biol. Chem. 260:8397-8403; 1985.
28. 3H-labeled 2-ethynylnaphthalene-inactivated P450 2B1 and 2B4 using amino acid sequencing and mass spectrometry. Biochemistry 33:3766-3771; 1994.
29. 29. Roberts, E. S.; Hopkins, N. E.; Alworth, W. L.; Hollenberg, P. F. Mechanism-based inactivation of cytochrome P450 2B1 by 2-ethynylnaphthalene: Identification of an active-site peptide. Chem. Res. Toxicol. 6:470-479; 1993.
30. 30. Stadtman, E. R. Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal-catalyzed reactions. Annu. Rev. Biochem. 62:797-821; 1993.
31. 31. Yao, K.; Falick, A. M.; Patel, N.; Correia, M. A. Cumene hydroperoxide-mediated inactivation of cytochrome P450 2B1. Identification of an active site heme-modified peptide. J. Biol. Chem. 268:59-65; 1993.
32. 32. Catalano, C. E.; Choe, Y. S.; Ortiz de Montellano, P. R. Reactions of the protein radical in peroxide-treated myoglobin: Formation of a heme-protein cross-link. J. Biol. Chem. 264:10534-10541; 1989.
33. 33. Guengerich, F. P. Covalent binding to apoprotein is a major fate of heme in a variety of reactions in which cytochrome P-450 is destroyed. Biochem. Biophys. Res. Commun. 138:193-198; 1986.
34. 34. Davies, H. W.; Thomas, P. E.; Pohl, L. R. Activation of cytochrome P-450 heme in vivo. Adv. Exp. Med. Biol. 197:253-261; 1986.
35. 35. Davies, H. W.; Britt, S. G.; Pohl, L. R. Inactivation of cytochrome P-450 by 2-isopropyl-4-pentenamide and other xenobiotics leads to heme-derived protein adducts. Chem. Biol. Interact. 58:345-352; 1986.
36. 36. Davies, H. W.; Britt, S. G.: Pohl, L. R. Carbon tetrachloride and 2-isopropyl-4-pentenamide-induced inactivation of cytochrome P-450 leads to heme-derived protein adducts. Arch. Biochem. Biophys. 244:387-392; 1986.
37. 4 treatment of rats. Biochem. Pharmacol. 34:3203-3206; 1985.
38. 38. Osawa, Y.; Fellows, C.; Highet, R. J. Use of stable and radioactive isotopes to identify reactive metabolites and target macromolecules associated with toxicities of halogenated hydrocarbons. In: Buncel, E.; Kabalka, G. W., eds. Synthesis and application of isotopicaliy labelled compounds 1991, proceedings of the fourth international symposium, Toronto. Canada. Amsterdam: Elsevier Science; 1992:415-420.
39. 39. Fuhrhop, J. H.; Smith, K. M. Laboratory methods. In: Smith, K. M., eds. Porphyrins and metalloporphyrins. New York: Elsevier Scientific Publishing Co.: 1975:757-869.
40. 40. Guengerich, F. P. Destruction of heme and hemoproteins mediated by liver microsomal reduced nicotinamide adenine dinucleotide phosphate cytochrome P-450 reductase. Biochemistry 17:3633-3639; 1978.
41. 41. Schaefer, W. H.; Harris, T. M.; Guengerich, F. P. Characterization of the enzymatic and nonenzymatic peroxidative degradation of iron porphyrins and cytochrome P-450 heme. Biochemistry 24:3254-3263; 1985.
42. 42. Giulivi, C.; Davies, K. J. A. A novel antioxidant role for hemoglobin: The comproprotionation of ferrylhemoglobin with oxyhemoglobin. J. Biol Chem. 265:19453-19460; 1990.
43. 43. Galaris, D.; Cadenas, E.; Hochstein, P. Redox cycling of myoglobin and ascorbate: A potential protective mechanism against oxidative reperfusion injury in muscle. Arch. Biochem. Biophys. 273:497-504; 1989.
44. 44. Galaris, D.; Cadenas, E.; Hochstein, P. Glutathione-dependent reduction of peroxides during ferryl- and met-myoglobin interconversion: A potential protective mechanism in muscle. Free. Radic. Biol. Med. 6:473-478; 1989.
45. 45. Galaris, D.; Eddy, L.; Arduini, A.; Cadenas, E.; Hochstein, P. Mechanisms of reoxygenation injury in myocardial infarction: Implications of a myoglobin redox cycle. Biochem. Biophys. Res. Commun. 160:1162-1168; 1989.
46. 46. Livingston, D. J.; La Mar, G. N.; Brown, W. D. Myoglobin diffusion in bovine heart muscle. Science 220:71-73; 1983.
47. 47. Arduini, A.; Eddy, L.; Hochstein, P. Detection of ferryl myoglobin in the isolated ischemic rat heart. Free. Radic. Biol. Med. 9:511-513; 1990.
48. 48. Gutteridge, J. M. C. Iron promoters of the Fenton reaction and lipid peroxidation can be released from haemoglobin by peroxides. FEBS. Lett. 201:291-295; 1986.
49. 49. Prasad, M. R.; Engelman, R. M.; Jones, R. M.; Das, D. K. Effects of oxyradicals on oxymyoglobin: Deoxygenation, haem removal and iron release. Biochem. J. 263:731-736; 1989.
50. 50. Harel, S.; Salan, M. A.; Kanner, J. Iron release from metmyoglobin, methaemoglobin and cytochrome c by a system generating hydrogen peroxide. Free. Radic. Res. Commun. 5:11-19; 1988.
51. 51. Puppo, A.; Halliwell, B. Formation of hydroxyl radicals from hydrogen peroxide in the presence of iron. Is haemoglobin a biological Fenton reagent? Biochem. J. 249:185-190; 1988.
52. 52. Ferrali, M.; Ciccoli, L.; Comporti, M. Allyl alcohol-induced hemolysis and its relation to iron release and lipid peroxidation. Biochem. Pharmacol. 38:1819-1825; 1989.
53. 53. Paller, M. S. Hemoglobin- and myoglobin-induced acute renal failure in rats: Role of iron in nephrotoxicity. Am. J. Physiol. 255:F539-F544; 1988.
54. 54. Reddy, B. R.; Kloner, R. A.; Przyklenk, K. Early treatment with deferoxamine limits myocardial ischemic/reperfusion injury. Free. Radic. Biol. Med. 7:45-52; 1989.
55. 55. Sakaida, I.; Kyle, M. E.; Farber, J. L. Autophagic degradation of protein generates a pool of ferric iron required for the killing of cultured hepatocytes by an oxidative stress. Mol. Pharmacol. 37:435-442; 1990.
56. 56. Sullivan, J. L. The iron paradigm of ischemic heart disease. Am. Heart J. 117:1177-1188; 1989.
57. 57. Davies, K. J. A.; Golberg, A. L. Oxygen radicals stimulate intracellular proteolysis and lipid peroxidation by independent mechanisms in erythrocytes. J. Biol. Chem. 262:8220-8226; 1987.
58. 58. Davies, K. J. A. Protein damage and degradation by oxygen radicals: I. General aspects. J. Biol. Chem. 262:9895-9901; 1987.
59. 59. Davies, K. J. A.; Delsignore, M. E. Protein damage and degradation by oxygen radicals: III. Modification of secondary and tertiary structure. J. Biol. Chem. 262:9908-9913; 1987.
60. 60. Davies. K. J. A.; Lin, S. W.; Pacifici, R. E. Protein damage and degradation by oxygen radicals: IV. Degradation of denatured protein. J. Biol. Chem. 262:9914-9920; 1987.
61. 61. Davies, K. J. A.; Lin, S. W. Oxidatively denatured proteins are degraded by an ATP-independent proteolytic pathway in Escherichia coli. Free. Radic. Biol. Med. 5:225-236; 1988.
62. 62. Fagan, J. M.; Waxman, L.; Goldberg, A. L. Red blood cells contain a pathway for the degradation of oxidant-damaged hemoglobin that does not require ATP or ubiquitin. J. Biol. Chem. 261:5705-5713; 1986.
63. 2. FASEB J. 7:A1074; 1993.